Brekiya 1 MG (equivalent to dihydroergotamine 0.86 MG) per 1 ML Auto-Injector

RxCUI: 2714315
RxNorm name: Brekiya 1 MG (equivalent to dihydroergotamine 0.86 MG) per 1 ML Auto-Injector
Display name: Brekiya 1 MG (equivalent to dihydroergotamine 0.86 MG) per 1 ML Auto-Injector
Full name: Brekiya 1 MG (equivalent to dihydroergotamine 0.86 MG) per 1 ML Auto-Injector
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
BREKIYA	DIHYDROERGOTAMINE MESYLATE	Amneal Pharmaceuticals LLC	cdbf5619-767f-4165-aec2-17bdd92d9ca2	2025-10-04	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2714315

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
cdbf5619-767f-4165-aec2-17bdd92d9ca2	Brekiya 1 MG (equivalent to dihydroergotamine 0.86 MG) per 1 ML Auto-Injector	SY	2	These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946	20251004
cdbf5619-767f-4165-aec2-17bdd92d9ca2	1 ML dihydroergotamine mesylate 1 MG/ML Auto-Injector [Brekiya]	SBD	2	These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946	20251004
cdbf5619-767f-4165-aec2-17bdd92d9ca2	1 ML Brekiya 1 MG/ML Auto-Injector	SY	2	These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946	20251004
cdbf5619-767f-4165-aec2-17bdd92d9ca2	1 ML DHE mesylate 1 MG/ML Auto-Injector [Brekiya]	SY	2	These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946	20251004
cdbf5619-767f-4165-aec2-17bdd92d9ca2	brekiya 1 MG in 1 ML Auto-Injector	PSN	2	These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946	20251004